The bill sets requirements relating to the prior authorization process for Medicare Advantage plans. The House's decision is supported by several healthcare advocacy organizations, including Better Medicare Alliance and the American Hospital Association. AHIP, however, neither criticized nor celebrated the passage.
Join us for an introduction to the OBGYN-specific EHR designed to adapt to the way OBGYNs specifically work. ModMed Presenters: Dr. Sherling, Chief Medical/Strategy Officer and OBGYN's: Dr. Ecklund, Medical Director & Dr. Spier, Team Lead
Join us September 28 at Pegasus Park in Dallas to meet select Employee Benefits Startups, over 30 investors, and to be a part of the thought provoking discussions around mental health, pharmacy benefits, the cost of healthcare, and reaching consumers.
As the U.S. healthcare industry continues to advance value-based care and population health, lab testing price transparency and payment integrity programs should be a priority.
Israeli medical device company Brainsway earned a positive coverage policy from Cigna for its deep transcranial magnetic stimulation to treat adult patients with OCD. Cigna joins the ranks of other major insurers who cover the device for OCD treatment — including Centene, Highmark, Blue Cross Blue Shield, Tricare and Palmetto GBA.
By Frank Vinluan Friday, September 16, 2022 1:30 PM
Intellia Therapeutics has encouraging early clinical data for a gene-editing therapy addressing the rare swelling disorder hereditary angioedema. This therapy, the biotech's second CRISPR-editing based treatment that performs in vivo edits, offers potential for a one-time treatment of a disease that is currently addressed by chronic oral and injectable drugs.
No comments